Stocks

Lupin, Natco Pharma gets USFDA approval for breast cancer injection; here's how the stocks are faring

Eribulin mesylate injection has an estimated annual sales of $43.7 million in the US

U2Fx.comU2Fx.com
Jun 3, 2026 - 12:00
 0  1
Lupin, Natco Pharma gets USFDA approval for breast cancer injection; here's how the stocks are faring
Eribulin mesylate injection has an estimated annual sales of $43.7 million in the US
Read More

Tags:

Previous Article

Stock market crash: ITC, Patanjali Foods, Britannia, SBI Cards among 51 stocks t...

Next Article

Japan’s stock market hits new record as AI boom gathers steam

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

U2Fx.com
U2Fx.com

Related Posts

When are HDFC, ICICI Q3 results out? Indian investors in banking stocks await quarterly earnings: South Indian Bank results today

When are HDFC, ICICI Q3 results out? Indian investors i...

U2Fx.com Jan 15, 2026  0  24

Not property or stocks, can investing in luxury be the next big move for India's middle class?

Not property or stocks, can investing in luxury be the ...

U2Fx.com Nov 14, 2025  0  17

Israel warns U.S. of ‘critically low’ interceptor stocks amid Iran war

Israel warns U.S. of ‘critically low’ interceptor stock...

U2Fx.com Mar 15, 2026  0  16